← Leaderboards
Howard M Deutsch
Georgia Institute Of Technology
$1,513,727
Attributed
$1,513,727
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,513,727 · 1
By mechanism
R01$1,513,727 · 1
Top collaborators
No co-investigators on record.
Most similar at Georgia Institute Of Technology
Same institution · by research overlap
- Susanna Coons$43,624
- Sahar Javanmard$21,324
Others in their field
Top investigators on “Analog”
- David Heimbrook · Leidos Biomedical Research, Inc.$196,589,777
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Norman Wolmark · Nsabp Foundation, Inc.$51,982,954
- Robert Turner Schooley · University Of Colorado Denver$48,513,949
- Kenneth A Bloom · University Of Nebraska-Lincoln$46,979,168
- John Hobbs · Suny At Stony Brook$41,239,084
Research focus
AnalogBicyclic CompoundBinding SitesChemical ModelsChemical StructureCocaineCravingDopamine AgonistsDopamine AntagonistsDopamine TransporterDrug Abuse ChemotherapyDrug Design /Synthesis /ProductionDrug Screening /EvaluationIntermolecular InteractionLaboratory RatMacaca MulattaMethylphenidateNarcotic AntagonistsNorepinephrinePharmacokineticsSerotoninSubstance Abuse Related Behavior
Grant awards (7)
PRECLINICAL DEVELOPMENT OF DRUGS FOR STIMULANT ABUSE$293,680
R01 · FY2003 · DA
PRECLINICAL DEVELOPMENT OF DRUGS FOR STIMULANT ABUSE$373,959
R01 · FY2002 · DA
PRECLINICAL DEVELOPMENT OF DRUGS FOR STIMULANT ABUSE$378,722
R01 · FY2001 · DA
PRECLINICAL DEVELOPMENT OF DRUGS FOR STIMULANT ABUSE$70,810
R01 · FY2001 · DA
PRECLINICAL DEVELOPMENT OF DRUGS FOR STIMULANT ABUSE$2,500
R01 · FY2001 · DA
PRECLINICAL DEVELOPMENT OF DRUGS FOR STIMULANT ABUSE$391,129
R01 · FY2000 · DA
PRECLINICAL DEVELOPMENT OF DRUGS FOR STIMULANT ABUSE$2,927
R01 · FY2000 · DA